Abstract:AIMTo investigate the role of T helper 17 cells (Th17) and regulatory T cells (Treg) in hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF).METHODSWe enrolled 79 patients with HBV infection into the study, 50 patients with HBV-related ACLF and 29 patients with chronic hepatitis B (CHB), from the First Affiliated Hospital of Medical College from January 2009 to June 2012. The ACLF patients were diagnosed according to the criteria recommended by The 19(th) Conference of the Asian Pacific Association for the Study of the Liver in 2009. Twenty healthy individuals with a similar gender and age structures to the two patient groups were also included as the normal controls (NC). Of the 50 ACLF patients, 28 were subsequently classified as non-survivors: 19 patients died from multi-organ failure, 3 underwent liver transplantation, and 6 discontinued therapy during follow-up because of financial reasons. The remaining 22 ACLF patients whose liver and anticoagulation function recovered to nearly normal levels within the next 6 mo were classified as survivors. The number of circulating Treg and Th17 cells was determined upon diagnosis and during the 8th week of follow-up through flow cytometry.RESULTSThe percentage of circulating Treg cells in the ACLF group was significantly higher than that in the CHB group (5.50% ± 1.15% vs 3.30% ± 1.13%, P < 0.01). The percentages of circulating Th17 cells in the ACLF and the CHB groups were significantly higher than that in the NC group (6.32% ± 2.22% vs 1.56% ± 0.44%, P < 0.01; 3.53% ± 1.65% vs 1.56% ± 0.44%, P < 0.01). No significant difference in Treg cell to Th17 cell ratio was observed between the ACLF group and the CHB group (0.98 ± 0.44 vs 1.12 ± 0.64, P = 0.991), whereas those in the two HBV infection groups were significantly lower than that in the NC group (1.85 ± 1.22; both P < 0.01). The percentage of Treg cells in the survivors during the 8(th) week of follow-up was significantly lower than that during peak ACLF severity [total bilirubin (TBIL) peak] (3.45% ± 0.97% vs 5.18% ± 1.02%, P < 0.01). The percentage of Th17 cells in survivors during the 8(th) week of follow-up was significantly lower than that during the peak TBIL (2.89% ± 0.60% vs 5.24% ± 1.46%; P < 0.01). The Treg cell to Th17 cell ratio during the 8(th) week of follow-up was significantly higher than that during the TBIL peak (1.22 ± 0.36 vs 1.10 ± 0.54; P < 0.05).CONCLUSIONRestoring the Treg cell to Th17 cell ratio during the follow-up phase of ACLF could maintain the immune system at a steady state, which favours good prognosis.

Th17 cells in patients with HBV-related acute-on-chronic liver failure

Th17 Cells over 5.9% at Admission Indicate Poor Prognosis in Patients with HBV-related Acute-on-chronic Liver Failure

Frequency of Th17 and Treg in HBV-related acute-on-chronic liver failure and its clinical value

Persistently Elevated Circulating Th22 Reversely Correlates with Prognosis in Hbv-Related Acute-On-Chronic Liver Failure

Correlation Between Th17 and Ntreg Cell Frequencies and the Stages of Progression in Chronic Hepatitis B

The Ratio of Th-17 to Treg Cells is Associated with Survival of Patients with Acute-on-chronic Hepatitis B Liver Failure.

Study on Relationship between Th17 Cells,Th17 Cytokine and the Inflammatory Activity of Liver Tissue in Posthepatitis B Cirrhosis

Interleukin-17-Producing Cd4(+) T Cells Increase with Severity of Liver Damage in Patients with Chronic Hepatitis B

Increased IL-17-producing CD8(+) T Cell Frequency Predicts Short-Term Mortality in Patients with Hepatitis B Virus-Related Acute-on-chronic Liver Failure

Regulatory T Cells And Il-17(+) T Helper Cells Enhanced In Patients With Chronic Hepatitis B Virus Infection

Implication of Th17 and Th1 Cells in Patients with Chronic Active Hepatitis B

High Level of Il-27 Positively Correlated with Th17 Cells May Indicate Liver Injury in Patients Infected with Hbv

Imbalance of interleukin-17-producing CD4 T cells/regulatory T cells axis occurs in remission stage of patients with hepatitis B virus-related acute-on-chronic liver failure.

Circulating Th17 Cells Frequency is Associated with the Disease Progression in HBV Infected Patients

Restoring the Treg Cell to Th17 Cell Ratio May Alleviate Hbv-Related Acute-On-Chronic Liver Failure

Th17,Treg and Th17/Treg in Peripheral Blood of Patients with Hepatitis B Virus-Related Subacute-on-chronic Liver Failure and Their Relevance with Model for End-Stage Liver Disease Score

Th17/Treg Imbalance and Increased Interleukin-21 Are Associated with Liver Injury in Patients with Chronic Severe Hepatitis B.

Clinic Effects of IL-35 and Th17/Treg Cells in Patients with Chronic Hepatitis B Virus

Increased Th17 Cells Contribute to Disease Progression in Patients with Hbv-Associated Liver Cirrhosis

Imbalance of interleukin‐17‐producing <scp>CD</scp>4 <scp>T</scp> cells/regulatory <scp>T</scp> cells axis occurs in remission stage of patients with hepatitis <scp>B</scp> virus‐related acute‐on‐chronic liver failure

Expressions of Th17 cell-related cytokines in liver tissue of chronic hepatitis B